靶点- |
|
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期- |
A randomized doble-blind placebo-controlled study to assess the safety in a one-year of orally administered microencapsulated ragweed pollen extract
Assessment of the Maximal Tolerated Dose of a Microencapsulated House Dust Mite (Dermatophagoides pteronyssinus and Dermatophagoides farinae) Extract (MHDME) in Subjects with House Dust Mite Allergy in a Randomized, Double-Blind, Placebo-Controlled Study - DME_01
A randomized, double-blind, parallel group, placebo-controlled study to assess the efficacy and safety of two doses of oral microencapsulated grass pollen extract administered prior to and during the the grass pollen season
100 项与 Curalogic AS 相关的临床结果
0 项与 Curalogic AS 相关的专利(医药)
100 项与 Curalogic AS 相关的药物交易
100 项与 Curalogic AS 相关的转化医学